Last update: Dec. 21, 2013


High Risk for breastfeeding

Poorly safe. Evaluate carefully.
Use safer alternative or interrupt breastfeeding 3 to 7 T ½ (elimination half-lives).
Read the Comment.

Psycho-stimulant used for treatment of Attention Deficit and Hyperactivity Disorder.

On latest update relevant data on breastfeeding was not found.

Although a high plasma protein binding makes excretion into breast milk likely very low, until more information concerning breastfeeding is available, a safer alternative is preferred.


Suggestions made at e-lactancia are done by APILAM´s pediatricians and pharmacists, and are based on updated scientific publications.
It is not intended to replace the relationship you have with your doctor but to compound it.

Jose Maria Paricio, Founder & President of APILAM/e-Lactancia

Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.

Thank you for helping to protect and promote breastfeeding.

José María Paricio, founder of e-lactancia.

Other names

Tomoxetine is also known as Atomoxetine.


Tomoxetine belongs to this group or family:


Main tradenames from several countries containing Tomoxetine in its composition:


Variable Value Unit
Oral Bioavail. 63 - 94 %
Molecular weight 291 daltons
Protein Binding 98 %
VD 0,9 l/Kg
Tmax 1 - 2 hours
T1/2 5 - 21 hours


  1. Cui YM, Teng CH, Pan AX, Yuen E, Yeo KP, Zhou Y, Zhao X, Long AJ, Bangs ME, Wise SD. Atomoxetine pharmacokinetics in healthy Chinese subjects and effect of the CYP2D6*10 allele. Br J Clin Pharmacol. 2007 Abstract Full text (in our servers)
  2. Sauer JM, Ring BJ, Witcher JW. Clinical pharmacokinetics of atomoxetine. Clin Pharmacokinet. 2005 Abstract

Total visits


Help us improve this entry

How to cite this entry

Do you need more information or did not found what you were looking for?

   Write to us at

e-lactancia is a resource recommended by Asociación Pro Lactancia Materna (APROLAM) from Mexico

Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM